NASDAQ : HCTI
Healthcare Triangle, Inc. — Key statistics
Healthcare · Health Information Services · United States
Last price 6.3 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 4.72M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 3.85M |
| Enterprise Value | 14.83M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 748,716 |
| Shares Outstanding | 748,716 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +201.45% |
| Owned by Insiders (%) | 6.99% |
| Owned by Institutions (%) | 0.31% |
| Float | 627,501 |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.15 |
| Forward PS | 0.19 |
| PB Ratio | 0.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.60 |
| Quick Ratio | 0.57 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -48.29 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -57.41% |
| Return on Assets (ROA) | -20.87% |
| Return on Invested Capital (ROIC) | -24.68% |
| Return on Capital Employed (ROCE) | -25.55% |
| Weighted Average Cost of Capital (WACC) | 3.78% |
| Revenue Per Employee | $641,850 |
| Profits Per Employee | -$425,575 |
| Employee Count | 40 |
| Asset Turnover | 0.58 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 24,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -99.86% |
| 50-Day Moving Average | 12.68 |
| 200-Day Moving Average | 68.27 |
| Relative Strength Index (RSI) | 24.99 |
| Average Volume (20 Days) | 18,444 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 252,895 |
| Short Previous Month | 767,059 |
| Short % of Shares Out | 33.78% |
| Short % of Float | 40.30% |
| Short Ratio (days to cover) | 0.06 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 25.67M |
| Gross Profit | 5.53M |
| Operating Income | -14.73M |
| Pretax Income | -17.00M |
| Net Income | -17.02M |
| EBITDA | -13.09M |
| EBIT | -14.73M |
| Loss Per Share | -$429.56 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.02M |
| Total Debt | 13.00M |
| Net Cash | -10.98M |
| Net Cash Per Share | -$14.67 |
| Equity (Book Value) | 49.10M |
| Book Value Per Share | 234.28 |
| Working Capital | -6.34M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -16.03M |
| Capital Expenditures | 547,000 |
| Depreciation & Amortization | 1.63M |
| Net Borrowing | 13.03M |
| Free Cash Flow | -15.48M |
| FCF Per Share | -$20.68 |
Margins
| Measure | Value |
|---|
| Gross Margin | 21.52% |
| Operating Margin | -57.37% |
| Pretax Margin | -66.21% |
| Profit Margin | -66.30% |
| EBITDA Margin | -51.00% |
| EBIT Margin | -57.37% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -8,357.18% |
| FCF Yield | -402.27% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 36.29% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 26, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.21 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |